摘要:
The disclosure discloses an application store system and a development method using the application store system. The application store includes a developer community function entity, an application network store function entity and a telecommunication capability resource function entity. The telecommunication capability resource function entity includes a service execution module, configured to call, through an interface, a telecommunication capability in an integrated service access gateway to execute a service with the telecommunication capability, wherein the service is configured to be embedded in an application; the service with the telecommunication capability executed by the service execution module of the telecommunication capability resource function entity is embedded in the application uploaded in the developer community function entity. With the disclosure, development of the application with the telecommunication capability is accomplished, thereby the profit of operator is guaranteed and the viability of operator in the future is enhanced.
摘要:
The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.
摘要:
The present application relates to anti-PD-L1 antibodies, which have therapeutic use to enhance T-cell function to upregulate cell-mediated immune responses and for the treatment of T cell dysfunctional disorders, including infection (e.g., acute and chronic) and tumor immunity.
摘要:
The invention provides crystal structures of neuropilin 1 (Nrp1) and neuropilin 2 (Nrp2) fragments alone and in complex with anti-neuropilin antibodies, and method for their use. The invention further provides anti-Nrp antibodies and methods for their therapeutic applications.
摘要:
Novel anti-NRP1 antibodies and variants thereof having unique structural and functional characteristics are disclosed. Also provided are uses of the antibodies in research, diagnostic and therapeutic applications.
摘要:
The present invention relates to the use of VEGF antagonists and a novel anti-α5β1 antibody for treating cancer and inhibiting angiogenesis and/or vascular permeability, including inhibiting abnormal angiogenesis in diseases. The present invention also relates to compositions and kits comprising novel anti-α5β1 antibodies and methods of making and using them.
摘要:
The present invention discloses a location processing method, an address duplication processing method and apparatus based on an integrated service access gateway/Parlay X gateway. The location processing method includes that: the integrated service access gateway/Parlay X gateway receives location operation requests for multiple terminals by a provided network service interface, wherein the location operation requests are location requests simultaneously initiated for the addresses of multiple terminals; and the integrated service access gateway/Parlay X gateway processes the location operation requests via a service logic processing module, processes the location operation requests according to a predetermined policy in a case that address duplication occurs in the addresses of multiple terminals, and returns policy duplication abnormality and/or location results via the network service interface. The present invention solves the problems of low system developing efficiency and low service processing speed resulting from the processing of user's address duplication in the ISAG/Parlay X gateway, and further achieves the effects of improving the execution efficiency of location service, shortening the response time, and improving the efficiency of developing.